NCT00707538View on ClinicalTrials.gov

A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Healthy Volunteers
Interventions
DRUG

BMS747158

2 IV injection of \~11 mCi (total) F-18 labeled compound

Trial Locations (2)

21287

John Hopkins University, Baltimore

90095

UCLA Medical Center, Los Angeles

Sponsors
All Listed Sponsors
lead

Lantheus Medical Imaging

INDUSTRY